AMZN vs EBS · P/E 31, rev $200.61B vs rev $1.04B
Amazon.com Inc (AMZN) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andy Jassy.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMZN revenue for 2026-06-30 was $200.61B. Net income was $62.65B. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AMZN currently screens at market cap $2.55T and trailing P/E 30.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AMZN and EBS stock pages for the full models.
Not investment advice.